» Authors » James Pellicane

James Pellicane

Explore the profile of James Pellicane including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 39
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah C, Whitworth P, Vicini F, Narod S, Gerber N, Jhawar S, et al.
Ann Surg Oncol . 2024 Jun; 31(9):5919-5928. PMID: 38916700
Background: Breast-conserving surgery (BCS) followed by adjuvant radiotherapy (RT) is a standard treatment for ductal carcinoma in situ (DCIS). A low-risk patient subset that does not benefit from RT has...
2.
Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, et al.
Ann Surg Oncol . 2021 May; 28(Suppl 3):878. PMID: 33997922
No abstract available.
3.
Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, et al.
Ann Surg Oncol . 2021 Apr; 28(11):5974-5984. PMID: 33821346
Background: The role of radiation therapy (RT) following breast-conserving surgery (BCS) in ductal carcinoma in situ (DCIS) remains controversial. Trials have not identified a low-risk cohort, based on clinicopathologic features,...
4.
Weinmann S, Leo M, Francisco M, Jenkins C, Barry T, Leesman G, et al.
Clin Cancer Res . 2020 Apr; 26(15):4054-4063. PMID: 32341032
Purpose: A major challenge in ductal carcinoma (DCIS) treatment is selection of the most appropriate therapeutic approach for individual patients. We conducted an external prospective-retrospective clinical validation of a DCIS...
5.
Beitsch P, Whitworth P, Baron P, Pellicane J, Treece T, Yoder E, et al.
Ann Surg Oncol . 2016 Jul; 23(10):3317-23. PMID: 27384749
Purpose: Neoadjuvant therapy (NAT) has been shown to clinically downstage locally advanced breast cancers. This study aimed to determine whether a meaningful change in gene signatures occurs between pre- and...